Leslie R. Boyd

1.3k total citations
60 papers, 949 citations indexed

About

Leslie R. Boyd is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Leslie R. Boyd has authored 60 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Reproductive Medicine, 19 papers in Oncology and 19 papers in Obstetrics and Gynecology. Recurrent topics in Leslie R. Boyd's work include Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Uterine Myomas and Treatments (8 papers). Leslie R. Boyd is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Uterine Myomas and Treatments (8 papers). Leslie R. Boyd collaborates with scholars based in United States, Japan and United Kingdom. Leslie R. Boyd's co-authors include John P. Curtin, Akiva P. Novetsky, Franco M. Muggia, Donald Maxwell Parkin, Stephanie V. Blank, Bhavana Pothuri, Jessica Lee, Melissa K. Frey, Yindalon Aphinyanaphongs and Kazuhiko Yamada and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Leslie R. Boyd

55 papers receiving 918 citations

Peers

Leslie R. Boyd

SURGE

ONCOL

Simon Butler‐Manuel United Kingdom

Jason C. Barnett United States

Ottavia D’Oria Italy

Giuseppe Scaletta Italy

Akiva P. Novetsky United States

Joshua P. Kesterson United States

Sumonmal Manusirivithaya Thailand

Mark S. Carey Canada

Wolfgang Janni Germany

Henrik Lajer Denmark

Simon Butler‐Manuel United Kingdom

Leslie R. Boyd

360 ×1.2

277 ×0.9

SURGE

420 ×1.7

186 ×0.8

ONCOL

222 ×1.2

Citations per year, relative to Leslie R. Boyd Leslie R. Boyd (= 1×) peers Simon Butler‐Manuel

Countries citing papers authored by Leslie R. Boyd

Since Specialization

Citations

This map shows the geographic impact of Leslie R. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie R. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie R. Boyd more than expected).

Fields of papers citing papers by Leslie R. Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie R. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie R. Boyd. The network helps show where Leslie R. Boyd may publish in the future.

Co-authorship network of co-authors of Leslie R. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie R. Boyd. A scholar is included among the top collaborators of Leslie R. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie R. Boyd. Leslie R. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Punekar, Salman R., J. Randolph Hecht, Diane M. Simeone, et al.. (2024). EVEREST-2: A seamless phase 1/2 study of A2B694, a mesothelin (MSLN) logic-gated Tmod CAR T-cell therapy, in patients with solid tumors that show MSLN expression and human leukocyte antigen (HLA)-A*02 loss of heterozygosity (LOH).. Journal of Clinical Oncology. 42(16_suppl). TPS2699–TPS2699. 5 indexed citations

Colangelo, Nicholas, et al.. (2023). Evaluation of Sexual Side Effects in Patients after Chemoradiation and Brachytherapy for Gynecologic Cancers Involving the Lower Vagina and Bulboclitoris. International Journal of Radiation Oncology*Biology*Physics. 117(2). e551–e551.

Lee, Sarah S., et al.. (2023). Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258. International Journal of Gynecological Cancer. 33(9). 1408–1418. 1 indexed citations

Boyd, Leslie R., et al.. (2023). Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to cervical cancer questions. Gynecologic Oncology. 179. 164–168. 30 indexed citations

Boyd, Leslie R., et al.. (2021). Preoperative MRI and LDH in women undergoing intra-abdominal surgery for fibroids: Effect on surgical route. PLoS ONE. 16(2). e0246807–e0246807. 2 indexed citations

Boyd, Leslie R., et al.. (2021). Determinants of Clinic Absenteeism in Gynecologic Oncology Clinic at a Safety Net Hospital. Journal of Community Health. 46(2). 399–404. 1 indexed citations

Frey, Melissa K., Sarah S. Lee, Zachary Schwartz, et al.. (2020). Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression. Gynecologic Oncology. 157(1). 280–286. 7 indexed citations

Meyer, Jessica A., et al.. (2019). Magnetic Resonance Imaging to Rule out Leiomyosarcoma in Patients Undergoing Surgery for Leiomyomas: A Real World Experience in an Unenhanced Patient Population. Journal of Gynecologic Surgery. 35(6). 363–369. 1 indexed citations

Frey, Melissa K., Fernanda Musa, Franco M. Muggia, et al.. (2019). Neoadjuvant chemotherapy in patients with advanced endometrial cancer. Cancer Chemotherapy and Pharmacology. 84(2). 281–285. 28 indexed citations

10.

Ko, Emily, Laura J. Havrilesky, Ronald D. Alvarez, et al.. (2018). Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP). Gynecologic Oncology. 149(2). 232–240. 9 indexed citations

11.

Lee, Jessica, John P. Curtin, Franco M. Muggia, et al.. (2018). Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer. Cancer Chemotherapy and Pharmacology. 82(1). 55–63. 5 indexed citations

12.

Wright, Jason D., Laura J. Havrilesky, Ronald D. Alvarez, et al.. (2018). Development of an alternative payment model (APM) for early-stage cervical cancer: Opportunities to reduce cost and improve quality. Gynecologic Oncology. 149. 6–6. 3 indexed citations

13.

Frey, Melissa K., Sarah H. Kim, Rachelle Chambers, et al.. (2017). Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes. Gynecologic Oncology. 146(1). 123–128. 16 indexed citations

14.

Frey, Melissa K., et al.. (2016). Cervical cancer screening in Santiago Atitlán, Guatemala. International Journal of Gynecology & Obstetrics. 135(1). 119–119. 1 indexed citations

15.

Lee, Jessica, et al.. (2016). The safety of same-day discharge after laparoscopic hysterectomy for endometrial cancer. Gynecologic Oncology. 142(3). 508–513. 42 indexed citations

16.

Boyd, Leslie R., et al.. (2014). A prospective comparison of postoperative pain and quality of life in robotic assisted vs conventional laparoscopic gynecologic surgery. American Journal of Obstetrics and Gynecology. 212(2). 194.e1–194.e7. 18 indexed citations

17.

Parkin, Donald Maxwell & Leslie R. Boyd. (2011). 4. Cancers attributable to dietary factors in the UK in 2010. British Journal of Cancer. 105(S2). S19–S23. 19 indexed citations

18.

Parkin, Donald Maxwell & Leslie R. Boyd. (2011). 8. Cancers attributable to overweight and obesity in the UK in 2010. British Journal of Cancer. 105(S2). S34–S37. 63 indexed citations

19.

Boyd, Leslie R., Akiva P. Novetsky, & John P. Curtin. (2010). Ovarian cancer care for the underserved: Are surgical patterns of care different in a public hospital setting?. Cancer. 117(4). 777–783. 17 indexed citations

20.

Wang, Fengqiang, et al.. (2010). Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity. Gynecologic Oncology. 117(1). 88–95. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact